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“You woke up this morning to what is effectively a 29-hour day. Twenty-four of those hours, 
you will use now; the other five will be put by for later”. Thomas B.L. Kirkwood 
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Summary of papers 
 
Paper I  
Routine morphological scoring systems in assisted reproduction treatment are based on 
parameters that presumably correlate with the biological quality of gametes and embryos, 
including chromosome abnormalities. Maternal age is a key factor predicting pregnancy and 
live birth, and it is therefore of considerable interest to identify age-related indicators of 
oocyte and embryo quality. The purpose of Paper I was to examine whether routine 
morphological scoring systems reflect age-related impact on oocyte and embryo quality 
among 4587 couples undergoing their first assisted reproduction treatment. The study 
assessed over 43,000 oocytes, 25,000 embryos and 7900 transferred embryos and analyzed 
the associations among the following parameters: number of oocytes retrieved, oocyte 
quality, including maturity, fertilization rates, embryo quality, based on morphological 
features, and treatment outcome. Advanced chronological age was found to be associated 
with fewer oocytes retrieved, fewer embryos available for cryopreservation, as well as lower 
pregnancy, implantation, live birth rates and a higher miscarriage rate. No age-related 
correlation was found between fertilization rates, oocyte or embryo quality. Routinely used 
morphological scoring systems, such as assessment of blastomere count, shape and 
fragmentation, fail to reflect age-related impact on oocyte and embryo quality. 
 
 
Paper II  
Advanced glycation end-products (AGEs) are formed by non-enzymatic glycation of proteins, 
lipids, and DNA. AGEs are involved in the pathogenesis of diabetes mellitus, cardiovascular 
disease, and Alzheimer’s disease. In reproductive ageing, intra-ovarian accumulation of AGE 
may induce oxidative stress-response through interaction with multi-ligand transmembrane 
receptors for AGE (RAGE). Accumulation of ageing-related molecular damage in ovarian 
somatic cells may also stimulate immune responses contributing to decline in ovarian 
function. In Paper II we aimed to determine whether follicular fluid-derived cells express 
AGE and the receptor RAGE and characterize downstream effects of RAGE activation, by 
immunofluorescence microscopy and multi-color flow cytometry. Both ovarian granulosa-
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lutein cells (GLC) and ovarian monocytes were found to express AGE and RAGE on the cell 
surface. RAGE-specific fluorescence intensity in GL cells correlated with the patients’ 
chronological age. GL cells, monocytes and lymphocytes were found to bind AGE-BSA, and 
the binding of AGE-BSA of GL cells correlated with the patients' chronological age. Binding of 
recombinant human chorionic gonadotrophin (rhCG) to GL cells was not affected by the 
presence of AGE-BSA. In GL cells, AGE-BSA and BSA failed to induce cleavage of caspase-3, 
phosphorylation of NF-κB, and increased binding of annexin V. AGE-fibronectin was found to 
induce detachment of cultured GL cells in vitro. The findings support that ovarian granulosa 
cells and monocytes are exposed to AGEs in vivo, express RAGE, and bind AGEs on the cell 
surface. The ligands of RAGE and their effects in the ovary remain uncertain. Structural long-
lived extracellular matrix (ECM) proteins rather than soluble AGEs may play a role in the 
decline of ovarian function during ageing. 
 
 
Paper III 
Cytoplasmic fragments are often observed during the first few cells divisions of developing 
human embryos in vitro. The fragments may contain genetic material, even whole 
chromosomes, and a high degree of embryo fragmentation predicts inferior development. 
The mechanisms involved in embryo fragmentation remain unclear, but given the 
association between fragments and aneuploidy, it has been hypothesized that 
fragmentation is related to temporal derangements during the cell cycle. The aim of Paper III 
was to study the fragmentation of human embryos and to explore the correlation between 
fragmentation and the duration of the meiotic and mitotic cell divisions, as assessed by 
polarized light microscopy of oocytes and time-lapse imaging of embryos. Embryos with a 
low degree of fragmentation were found to originate from oocytes that had a visible spindle 
within 35.5 hours, indicating an early completion of the first meiotic division. Time-lapse 
imaging of embryos revealed that asynchrony between the 2nd and 3rd mitotic divisions was 
related to a high degree of embryo fragmentation. We suggest that fragmentation of in 
vitro-derived embryos is related to the progress of the meiotic and the mitotic cell cycles.  
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1. General introduction  
Ovarian ageing as a topic and its associated effects on fertility has received greater attention 
as an increasing number of women in modern society choose to postpone the age at which 
they bear children. In Norway, mothers giving birth for the first time had an average age of 
28.6 years in 2013, while they were on average 22.9 years old in 1976  1. In 2012, for the first 
time in history, the majority of babies were born to mothers in the age group 30 – 34 years. 
Until 2012, women in the age group 25 – 29 years delivered most children 1. Moreover, 
Northern countries have observed a trend of decreasing fecundity. Indeed, the fecundity in 
Norway had decreased from 1.98 in 2009 to 1.78 in 2013 1. Older women have to face the 
natural limits of their own reproductive system, due to the fact that fecundity is reduced 
with increasing female age 2. Lessons from natural fertility populations show that the 
fecundity of women decreases gradually throughout her thirties, the decline becoming more 
significant by 35 of age and accelerating after 40 (Figure 1) 2. The mean age at menopause is 
50-51 years, whereas fertility already terminates ten years earlier, when the woman 
becomes sterile 2-4. Observations from reproductive biology, epidemiology, and clinical 
assisted reproduction support the hypothesis that the time interval between the onset of 
the accelerated decline of the ovarian reserve and the menopause is more or less fixed. Up 
to 10% of women in the general population are estimated to become menopausal by the age 
of 45 and 1% before the age of 40 5. These women may have experienced an accelerated 
decline of their fertility before the age of 32 or even earlier. This has been described as 
"early ovarian ageing" 4. Ovarian ageing is characterized by both a reduction in egg quality 
and a drastic reduction in the total number of ovarian follicles 2. 
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Figure 1: The distributions of age at the onset of subfertility (cumulative curve 1), at occurrence of 
natural sterility (cumulative curve 2), at transition into cycle irregularity (cumulative curve 3) and at 
occurrence of menopause (cumulative curve 4). Mean ages for these events are indicated on the x-
axis 2. 
 
1.1 Ovarian ageing 
In humans, it is firmly established that ovarian ageing progresses constantly during the 
reproductive lifespan. The relationship between aneuploidy rates in oocytes and increasing 
age has been established 6, 7. The reduction of oocyte quality with ageing is believed to be 
mainly due to an increase in meiotic nondisjunction that leads to an increased rate of 
aneuploidy in the early embryos 8. Aneuploidy is the leading cause of reduced fertility in 
females and developmental abnormalities in fetuses 6, 7, 9. Indeed, 10-30 % of all oocytes and 
50% of the blastocyst stage embryos over all maternal ages may carry a numerical 
chromosomal aberration 6, 10. The mechanisms involved in ovarian ageing are incompletely 
understood, but several hypotheses have been proposed. In sections 1.1.1 – 1.1.7 some 
prevailing hypotheses are briefly summarized. 
 
1.1.1 Limited oocyte pool hypothesis 
Although mitotically active oogonial stem cells have been claimed to be present in the 
ovaries of mice and humans, it is generally accepted that the population of primordial 
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follicles is fixed, it is established in the human ovaries during early fetal life, and it serves as 
the source of developing follicles and oocytes during the entire reproductive lifespan 11-13.  
Meiosis I in oocytes is initiated during fetal development, but suspended in diakinesis stage 
until ovulation, a pause that can last for up to 50 years 14. The number of oocytes decreases 
progressively: of 1 million follicles at birth, 450.000 follicles are left at the beginning of 
puberty and around 1000 oocytes at menopause 2, 4.The “the limited pool” hypothesis 
postulates that there exists a “production line”, so that oocytes that had been formed early 
during fetal life will ovulate first 15. According to this hypothesis, the oocyte cohort that 
enters the growing phase near the end of the reproductive lifespan has a reduced quality, 
because this late cohort has originated from oogonial stem cells that had undergone more 
cell divisions and thus may have accumulated more cellular damage 16, 17. 
“The limited pool” hypothesis would predict an increased incidence of trisomic pregnancies 
among women with reduced ovarian reserve independently of age, which has however not 
been confirmed by epidemiological data. Oocyte aneuploidy that characterizes biological 
ageing must therefore be determined by factors other than the size of the follicle pool 18. 
 
1.1.2 Two-hit hypothesis of aneuploidy 
The current understanding of aneuploidy in oocytes is dominated by the two-hit hypothesis 
19, 20. This model postulates that aneuploidy is a result of two consecutive events that affect 
the oocyte during fetal life and then during completion of meiosis in oocytes that had 
already been sensitized by the first event 20, 21. During the prophase I of meiosis I, 
homologous chromosomes pair up and form bivalents, which are aligned by the 
synaptonemal complex 22. The synaptonemal complex facilitates formation of crossing overs 
between homologues 23. Crossing overs are necessary to orient the sister kinetochores 
towards a single pole at metaphase I 24, 25. A prolonged lag between entering and completing 
meiosis may reduce the cohesive ties that hold sister chromatids together and predispose 
oocytes from older women to aneuploidy, constituting ‘the first hit’ 26. The second hit is an 
inability of the oocyte to detect and respond to recombination failure by activating cell cycle 
checkpoints, which may deteriorate with age, and thereby allow chromosomes to mis-
segregate during meiosis 24, 27.The cell cycle checkpoint may be sensitive to extrinsic, 
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environmental insults (e.g. smoking, pollutants, etc.), which would accelerate the intrinsic 
process of ageing accrued through cellular damage, e.g. by reactive oxygen species 21. 
Notably, both ‘hits’ are needed to occur in order to produce mis-segregated chromosomes.  
1.1.3 Weakened centromeric cohesion and cohesin loss 
The third hypothesis focuses on loading and stabilization of the cohesin complex. During 
mitosis, a protein complex consisting of four subunits, called cohesin, is required to hold 
sister chromatids together and allows their bi-orientation on the mitotic spindle; 
furthermore, cohesin is also important for DNA double strand-break repair and 
transcriptional control 28. During meiosis, the sister chromatids are held together from birth 
until ovulation by cohesin complexes whose ring structure consists of Rec8, SMC1β and SA3 
29, 30. The maintenance of cohesion between the homolog chromosomes requires 
preservation of a sufficient amount of cohesin on the sister chromatid centromeres and on 
the chromosome arms. Gradual decline of cohesin during the long arrest in prophase I may 
bring cohesin levels to fall below the threshold required to stabilize chiasmata and to hold 
sister centromeres tightly together, leading to chromosome mis-segregation during 
metaphase I 31. Age-related errors of meiosis I may be caused by the inability to regenerate 
cohesion in oocytes 30. SMC1β is a meiosis-specific cohesin that allows a controlled release 
of cohesion during meiosis 32. Cohesins are regulated by phosphorylation, acetylation, ATP 
hydrolysis, and site-specific proteolysis, as well as by interaction with cohesin protector 
proteins, such as Sgo2 28, 31. Indeed, cohesion at centromeres is protected by multiple factors 
including shugoshins (Sgo1 and Sgo2), aurora B kinase, and phosphatase PP2A 33-36. The 
shugoshins (Sgos) are conserved centromeric proteins. Sgo1 collaborates with protein 
phosphatase 2A (PP2A) to protect mitotic cohesin from the prophase dissociation pathway, 
and Sgo2 is required for the centromeric protection of cohesion in germ cells 34,36. Aurora B 
kinase (Aur-B) ensures bi-orientation of sister chromatids by destabilizing incorrectly 
attached kinetochore microtubules and participates in cytokinesis 34, 37. The cohesin present 
on the centromere of sister chromatids has to be protected against separase cleavage in 
anaphase I in order to prevent premature division of a chromosome into sister chromatids 
(predivision), which would result in random segregation and aneuploidy 38. Defects in the 
kinetochore, in cohesion, or in any of the factors that promote bi-orientation may lead to 
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chromosome mis-segregation and hence aneuploidy in the daughter cells 39. Predivision of 
chromatids is believed to be the major cause of meiotic errors and age-related increase in 
oocyte aneuploidy (Figure 2) 40. 
Figure 2: Schematic representation of copy number segregation patterns resulting from normal 
disjunction, non-disjunction of whole chromosomes and premature separation of chromatids in a 
mis-segregating chromosome. Maternal chromosomes are presented as red; paternal chromosomes 
are presented as blue. The segregation pattern is displayed on the right as gain (G), loss (L) or normal 
(N) copy number for PB1/PB2/Zygote40. 
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1.1.4 Function of the spindle assembly checkpoint (SAC) in meiosis 
During transition from late prometaphase to metaphase, the spindle assembly checkpoint 
(SAC) is activated in order to monitor proper attachment of chromosomes to spindle 
microtubules before anaphase 41-45. In mitosis, a signal from one unattached kinetochore is 
sufficient to arrest the cell cycle 46, 47. Tension across the centromere stabilizes correct 
attachments, whereas a mechanism involving aurora B kinase corrects the improperly 
attached chromosomes 48. In oocytes, the SAC guards against chromosomal mis-segregation 
but does not induce cell cycle arrest when a few achiasmatic chromosomes (univalents) are 
present, which may contribute to aneuploidy 49. Even multiple unaligned kinetochores and 
severe congression defects can be tolerated by the SAC at the metaphase to anaphase 
transition, indicating that the checkpoint mechanisms are insufficient in detection or 
correction of unaligned chromosomes 50. The age-related reduction in expression of 
components of the SAC in mammalian oocytes may act synergistically with reduced cohesion 
between sister chromatids and may predispose oocytes to chromosome segregation errors 
51. 
 
1.1.5 Global gene expression and DNA methylation 
An alternative hypothesis of ovarian ageing implies global changes in gene expression. 
During oocyte development, at primordial to primary follicle transition, there is a major 
change in the global gene expression, followed by a second major change during zygotic 
genome activation 52. Indeed, the gene expression profile of the 2-cell embryo differs 
markedly from oocytes, zygotes, and 8-cell embryos and blastocysts 52. In oocytes from 
ageing mice, 5% (530) of the 11,000 detected transcripts showed statistically significant 
expression changes, including genes involved in mitochondrial function, oxidative stress, 
chromatin structure, DNA methylation, and genome stability 53. 
 
1.1.6 Shortened telomeres in oocytes 
Eukaryotic cells have specialized non-coding DNA sequences at the ends of all chromosomes, 
called telomeres. The telomeres are protecting chromosome ends from being recognized as 
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DNA break by nucleases, preventing chromosomal fusions, and properly attaching the 
chromosome ends to the nuclear envelope. Telomeres in oocytes are believed to shorten 
with age and, when critically short, contribute to infertility and miscarriage 54, 55. Telomeres 
may also be shortened by exposure to reactive oxygen species, so the prolonged interval 
between fetal oogenesis and ovulation in some women may further contribute to telomere 
shortening 56. Telomere shortening in murine oocytes reduces synapsis and chiasmata, 
increases embryo fragmentation, cell cycle arrest, apoptosis, induces morphological defects 
of spindle, and chromosome abnormalities. Telomeres are shorter in the oocytes from 
women undergoing in vitro fertilization, and give increasingly rise to fragmented aneuploid 
embryos that fail to implant 57. 
1.1.7 Advanced glycation end products (AGEs) and the receptor RAGE 
A sixth hypothesis of ovarian ageing is the involvement of advanced glycation end products 
(AGEs), which may contribute to a compromised vascularization and activate an oxidative 
stress response through interaction with the receptor for advanced glycation end products 
(RAGE) 58. Glycation is the non-enzymatic addition of sugars to proteins, lipids and nucleic 
acids. AGEs are a heterogeneous, complex group of compounds that are formed mainly via 
the Maillard reaction, which was first described in 1912 by Louis Camille Maillard, a French 
16 years old scientist who studied the reaction between amino acids and sugars during 
heating 59, 60. The Maillard reaction occurs when a reducing sugar reacts in a non-enzymatic 
way with amino acids in proteins, with lipids, or with DNA 60. The formation of AGEs through 
the Maillard reaction is believed to proceed in three phases. In the first phase, glucose 
attaches non-enzymatically to a free amino acid, lipid or nucleic acid to form a reversible 
Schiff base 61. In the second phase, the Schiff base undergoes chemical rearrangement to 
form Amadori products, which are more stable than the Schiff base, but the reaction is still 
reversible 61. In the third phase, Amadori products accumulate and form crosslinked 
proteins, which is an irreversible process (Figure 3) 61. The final brownish products are called 
advanced glycation end products (AGEs). AGEs may interfere with normal cell function by 
inactivation of enzymes, abnormalities of nucleic acid function, inhibition of regulatory 
molecule binding, trapping of proteins by glycosylated extracellular matrix, altered 
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macromolecular recognition, and increased immunogenicity 61. AGEs have been associated 
with several age-related diseases, including diabetes mellitus, cardiovascular diseases, and 
Alzheimer’s disease 62-64. 
Figure 3: The formation of AGEs occurs in three phases. The results of the first phase are Schiff Bases, 
the second Amadori products and in the last phase AGEs are produced 65. 
The increased concentration of AGEs is believed to influence target cells by three general 
mechanisms: 1) alteration of function of intracellular proteins; 2) abnormal interaction of 
extracellular matrix components with other matrix components and with receptors for 
matrix proteins, such as integrins; 3) induction of receptor-mediated production of reactive 
oxygen spices (ROS) and cytokines via the AGE receptors (RAGEs) on endothelial cells, 
mesangial cells, and machrophages (Figure 4) 66.  
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Figure 4: Mechanisms by which intracellular production of advanced glycation end-product (AGE) 
precursors damages endothelial cells. Modification of extracellular matrix proteins causes abnormal 
interactions with other matrix proteins and with integrins. Modification of plasma proteins by AGEs 
creates ligands that bind to AGE receptors, inducing changes in gene expression in endothelial cells, 
mesangial cells and macrophages 66. 
The action of AGEs is classified as receptor independent or receptor dependent 67. AGEs 
circulating in the bloodstream may act on cell surface receptors, such as the receptor for 
AGE (RAGE), which is a member of the immunoglobulin superfamily of receptors68. RAGE has 
transmembrane, cytosolic and extracellular domains 69.  RAGE is abundantly expressed in 
many tissues, including the heart, lung, skeletal muscle, blood vessel wall, the ovaries, as 
well as in immune cells, including monocytes, macrophages, and lymphocytes 69. RAGE 
activates Nuclear Factor κB (NF-κB) and affects gene expression 66. RAGE is believed to be 
down-regulated in most organs in young individuals; with ageing, RAGE expression increases 
again, possibly due to the accumulation of RAGE ligands, which in turn up-regulate receptor 
expression 68-70. Ligand binding induces further up-regulation of RAGE causing a positive 
feedback loop 68. In addition to the full-length receptor expressed on the surface of cells, 
soluble isoforms of RAGE lacking both the cytosolic and the transmembrane domains have 
been described. These soluble forms of AGE receptors (sRAGE) are secreted by cells and can 
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be detected in the blood. sRAGE can bind ligands (AGEs) in the circulation, thus preventing 
the adverse cellular effects of AGE 71.Levels of AGEs in serum and tissues, including the 
ovary, seem to depend on endogenous and exogenous sources 72. The endogenous AGEs are 
produced in the body by chemical reactions. Exogenous sources of AGEs are diet and 
smoking 73. 
The accumulation of AGEs is associated with several reproductive pathologies, including 
polycystic ovarian syndrome (PCOS) and endometriosis 74-76. Accumulation of AGEs in tissues 
induces cellular oxidative stress and promotes inflammation 77. In the cases of diabetes, 
inflammation, atherosclerosis, and PCOS, there is a marked induction of RAGE due to the 
action of its ligands and due to immune mediators derived from activated inflammatory cells 
68, 70, 78. Concentration of circulating AGE derivates, such as carboxymethyl-lysine (CML) and 
methylglyoxal (MG), positively correlates with indicators of inflammation, such as C-reactive 
protein (CRP) 79.  
1.1.8 Leukocytes in ovarian function 
Granulosa cells (GCs) are somatic cells that surround the developing oocyte in the ovarian 
follicle 80. The functions of GCs include the production of growth factors that are vital for 
oocyte development and of sex steroids that regulate ovarian function. Following ovulation, 
GCs are luteinized and increasingly produce progesterone, which induces secretory 
transformation of the endometrium and supports pregnancy 81.  
Luteinized GCs (GLCs) are frequently used as a model for studying multiple aspects of 
ovarian function, since these cells can be readily collected by puncture of the ovarian follicle 
during assisted reproduction procedures. During ovum aspiration, however, the needle 
penetrates the vaginal wall, ovarian membranes and stroma, and the collected fluid is 
contaminated with tissue and blood components 82, 83, thus resulting in a heterogeneous cell 
population in which granulosa lutein cells (GLCs) are mixed with leukocytes 84-86, 
erythrocytes, as well as other cell types, such as endothelial and epithelial cells. Phenotypic 
characterization based on histochemical staining or leukocyte-specific immune markers has 
revealed the presence of macrophages, monocytes, granulocytes and lymphocytes among 
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these cells 87, 88. Nonetheless, since both circulating leukocytes (lymphocytes, monocytes, 
and granulocytes) and tissue-resident immune cells (macrophages/dendritic cells) are 
observed in the follicular fluid, it has been suggested that these immune cells originate both 
from a direct bleeding during aspiration and from tissue pieces that are collected in the 
aspirate 85. Interaction between ovarian somatic cells and immune cells is thought to be a 
key regulator of ovarian function. Leukocytes may regulate follicle growth, promote tissue 
re-organization around ovulation, vascularization and atrophy of corpus luteum. For 
example, it was shown that ovarian leukocytes increase release of matrix 
metalloproteinases, chemokines, and angiogenic factors by follicle fluid-derived cells (FFDC) 
89, 90. These interactions are probably mediated by soluble factors, as well as direct cell-cell 
interactions between leukocytes and ovarian somatic cells. Therefore, careful isolation 
techniques are necessary if we want to determine the specific role of granulosa cells in 
follicle development and ovarian function. Studies on luteinizing granulosa cells show that in 
women aged 38 years and older the granulosa cells are less numerous, produce less steroids 
and glycoproteins, contain lower levels of normal mitochondrial DNA (mtDNA), damaged 
mitochondria, and exhibit a reduced expression of antioxidant enzymes compared with GLCs 
derived from younger women 91-94. 
 
 
1.2 Assisted reproduction treatment in ageing women 
With a rising number of women postponing pregnancy until an advanced age, the demand 
for assisted reproductive technologies (ART) has increased. The growing popularity of ART 
has given the impression that female fertility may be manipulated at any stage of life; 
nonetheless, assisted reproduction technologies cannot reverse the “aged biological clock” 
of women in the 40’s 95. Female age is probably the most significant factor influencing 
clinical outcome in assisted reproduction treatments (ART), and there is a strong association 
between number of oocytes retrieved and live birth rates 96. Controlled ovarian 
hyperstimulation (COH) during ART induces simultaneous development of several follicles. 
The ovarian response to COH varies substantially among women and is believed to be 
dependent on the size of the pool of resting follicles, the so-called ovarian reserve, and the 
responsiveness of the follicles to exogenous stimulation of follicle stimulation hormones 
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(FSH) 97. In patients with low ovarian reserve, a reduced follicular response resulting in a low 
number of retrieved oocytes is achieved even when a high dose of gonadotrophins is 
administered. Tests for predicting ovarian reserve are available 98. The incidence of poor 
ovarian response is estimated to be between 9 – 24 %, values that increase with age and 
reach about 50% in women older than 40 years 99-102. The standard definition of poor ovarian 
response (POR) requires presence of at least two of the following three criteria: (i) advanced 
maternal age or any other risk factor for POR; (ii) a previous POR; and (iii) an abnormal 
ovarian reserve test (ORT). Two episodes of POR after maximal stimulation are sufficient to 
define a patient as poor responder in the absence of advanced maternal age or abnormal 
ORT 103. Women who respond poorly to COH have poor pregnancy prospects with a 
pregnancy rate varying from 7.6% to 17.5% compared with 25.9 – 36.7% in normal 
responders. Among the prognostic factors within the poor responder group, female age 
appears to play a distinct role. Overall, older poor responders have lower pregnancy rates 
(ranging between 1.5 – 12.7%) compared to younger poor responders (13.0 – 35%) 98. The 
median of age of women undergoing IVF in United Kingdom is around 36 years and by that 
time more that 90% of the ovarian reserve has been lost, and the chances of a live birth 
following IVF are severely reduced 104.  
 
As age increases, the risk of additional disorders that may adversely affect fertility, such as 
leiomyomas, tubal disease and endometriosis, also increase 105. Women with a history of 
prior ovarian surgery, chemotherapy, radiation therapy, severe endometriosis, pelvic 
infection, or a strong family history of early menopause may be at increased risk of having a 
premature decrease in the follicular pool and fertility decline. Ageing women more often 
experience pregnancies with complications, including spontaneous abortion, preeclampsia, 
gestational diabetes, and placenta previa, and the children of older mothers are increasingly 
affected by low birth weight, preterm birth, and perinatal mortality 106.  
 
1.3 Embryo assessments in assisted reproduction 
Identification of the embryo with the highest potential to implant, establish an ongoing 
pregnancy and a birth of a child is the assisted reproduction clinic’s primary aim. Embryo 
selection is based on methods that can give a direct or indirect clue regarding the potential 
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of a given embryo to implant. These methodologies are based on either invasive or 
noninvasive procedures, whereas the noninvasive procedures, described briefly in sections 
1.3.1 – 1.3.3, are routinely applied in assisted reproduction laboratories.  
 
1.3.1 Morphological embryo assessments 
In most IVF laboratories, embryo selection is based on morphological evaluation using light 
microscopy. There have been some concerns about the detrimental effects of light exposure 
on embryos or on cell culture media, but several publications reported no detrimental effect 
on embryo development of light exposure on mouse oocytes, rabbit embryos and human 
oocytes 107-110. Visual observations are typically carried out at three distinct developmental 
stages: fertilization, cleavage stage, and blastocyst stage. The morphological criteria 
considered include: number of pronuclei and polar bodies at fertilization (zygotes); cell 
number, degree of cellular fragmentation, evenness of mitotic divisions, presence of 
multinucleated blastomeres (cleavage stage embryos); extent of blastocoel expansion and 
assessments of inner cell mass (ICM) and trophectoderm (TE) (blastocysts) 111-115. Important 
considerations during morphological assessments of embryos include: 1) reducing the 
disturbance of embryo culture as much as possible (which may result in assessing embryos 
only once per day), 2) observing embryos at developmentally relevant time points.  
Morphological characteristics of gametes and embryos may predict implantation, pregnancy, 
and live birth 116.The rate of which the embryo development proceeds is believed to be of 
great importance, and transferred embryos that have four cells on day 2 and eight cells on 
day three post-insemination are expected to have a maximal implantation rate 117-119. 
Embryos that have cleaved more slowly than the expected rate have a reduced implantation 
potential, and embryos that have cleaved faster than the expected rate are likely to be 
chromosomally abnormal and also have a reduced implantation potential 117. 
 
Early cleavage is defined as a division to a two-cell embryo within 25- 27 hours post-
insemination, and its prognostic impact was first described by Edwards in 1984 120. Early 
cleavage is believed to correlate with increased pregnancy rates 121, 122.  
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Multinucleation is defined as the presence of more than one nucleus in a blastomere, 
including micronuclei, and is associated with chromosomal abnormalities, impaired 
developmental capacity, decreased implantation potential, and an increased risk of 
spontaneous abortion 115, 117, 123. In a recent study, the proportion of mononucleated 
blastomeres had a strong predicting power for live birth 119. Nonetheless, embryos with a 
binucleated blastomere at two cell stage can develop further, suggesting that embryos may 
correct multinucleation 124. 
Cleavage of embryos resulting in blastomeres with uneven size is supposed to negatively 
affect the developmental capacity of the embryo, lower pregnancy and implantation rates, 
and has been associated with multinucleation and aneuploidy  125, 126.  
A fragment is defined as an extracellular membrane-bound cytoplasmic structure that is < 45 
μm diameter in a day-2 embryo and < 40 μm diameter in a day-3 embryo 127. Fragmentation 
of human cleavage-stage embryos is a dynamic process with appearance of fragments and 
absorption in blastomeres 128. Fragments may also be positioned between blastomeres or 
along cell division planes and interfere with compaction, cavitation, and blastocyst formation 
129, 130. It has been demonstrated that fragments may contain even whole chromosomes, 
suggesting that fragments may contribute to aneuploidy in mosaic embryos 131. Embryo 
fragmentation in cleavage-stage embryos is found to be directly proportional to 
chromosomal abnormality 132, 133. Comparative genomic hybridization with DNA microarray 
revealed that high proportions of human blastocysts from women of advanced maternal age 
are aneuploid or mosaic 134. Indeed, fragmentation may qualify as an independent predictor 
of live birth, and only marginally less strong predictor than cleavage rate, and comparable to 
the presence of mononucleated blastomeres 119.  
1.3.2 Assessments of the meiotic spindle 
Visualization of the meiotic spindle by polarized light microscopy is a non-invasive tool to 
assess the developmental status of the oocyte. In life sciences, polarized light microscopy 
was used to visualize sperm as early as 1875, sea urchin embryos in 1937, and spindle 
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dynamics from the 1950s - 1970s 135. As technology has advanced and the technique become 
more sensitive and compatible with live cells and real-time imaging, it became available for 
routine examination of gametes and embryos 136-138. Polarized light microscopy instruments 
include an inverted light microscope fitted with a polarizer, a rotating liquid crystal retarder, 
a camera, and computer software to analyze the digital images 136. This technology uses 
polarized light to illuminate birefringent structures, which are highly ordered molecules such 
as microtubules in spindles or glycoproteins in zona pellucida (Figure 4) 139.  
 
 
 
Figure 4: Meiotic spindle and zona pellucida as seen by polarized microscopy, Polscope. 
 
The birefringent structures are visualized as bright objects, and the shift of wavelength of 
light while passing through the structure is measured as retardance (nm) 139. Presence of 
birefringent spindles in human oocytes is suggested to predict higher fertilization and 
embryo development rates 139-144. Although the clinical use of polarized microscopy is 
debated, the visualization of the meiotic spindle may provide insight into oocyte 
maturational or possibly chromosomal status 145, 146. It is important to note that the meiotic 
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spindle is a dynamic structure, and it is affected by environmental conditions, such as 
temperature 141, 147. 
Completion of the first meiotic division is marked by the formation of the first polar body 
(PB1), and failure to proceed to first polar body formation is termed meiosis I arrest. 
Metaphase I (MI) arrest is believed to occur because of a defect in the signal transduction 
pathway mediating meiotic progression or spindle abnormalities, which may result in 
activation of the spindle assembly checkpoint (SAC)148. Progression through meiosis I to 
metaphase II arrest requires chromosome condensation, formation of the metaphase 
spindle, chromosome alignment along the first metaphase plate, followed by the separation 
and segregation of homologous chromosomes. 
Metaphase II (MII) oocytes are generally considered as “mature” and are presumed to be 
capable to fertilization. Arrest at metaphase II is initiated and maintained by Emi2, the 
MOS/MAPK pathway, and SAC 149. Oocytes deficient in Emi2 were not able to form a spindle 
complex during meiosis II and were arrested at MII 150. 
 
1.3.3 Morphokinetic assessments of embryos 
In contrast to usual daily assessment that gives a snapshot of the dynamic process of embryo 
development, with time-lapse technology, embryos can be monitored without removing 
from the incubator and thereby maintaining optimal culture conditions. Several groups have 
affirmed that fertilization, embryo development, blastocyst formation and implantation 
potential of embryos cultures in time-lapse instruments is comparable to standard 
incubators 151-154. One of the first time-lapse studies of human embryo development was 
conducted in 1997 109. Since then, many papers have been published concerning the subject 
of time lapse imaging of human embryo development, especially morphokinetic assessment, 
which combines morphology with the timing of cell divisions. Nonetheless, there has been 
no consensus on whether time-lapse technology was improving live birth rates, safety, and 
cost effectiveness 155. Indeed, a recent Cochrane review concluded that there is insufficient 
evidence for a superior clinical outcome with time-lapse incubators over standard incubators 
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156. Furthermore, the utility of time-lapse technology to predict aneuploidy in human 
embryos has been highly debated 157-160. 
Nevertheless, time-lapse technology is a superior tool for studying the dynamic process of 
embryonic growth, as static observations are incapable of assessing progressive events and 
some important phenomena may be missed or overlooked 161. For example, it has been 
described that timing and synchrony of the first cleavage divisions is critical for normal 
development. In addition, traditional snapshots at specific developmental stages are 
unreliable to detect dynamic processes like multinucleation, emergence and disappearance 
of fragments, and collapse and re-expansion of blastocysts. 
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2. Aims of the thesis 
The aim of this thesis was to explore and evaluate clinical and molecular derangements 
associated with female reproductive ageing during assisted reproduction treatment. 
Specific objectives were: 
1) Examine whether morphological scoring systems routinely used in assisted 
reproduction laboratories reflect the female age-related impairment of oocyte and 
embryo quality. 
2) Explore whether the advanced glycation end products (AGEs) and the receptor 
(RAGE), known to be involved in other ageing-related diseases, are expressed on the 
surface of follicle fluid-derived cells. 
3) Study the process of fragmentation of human embryos and examine whether it was 
related to the progression through meiotic and mitotic cell cycles. 
Additional aims were: 
4) Assess whether visualization of the meiotic spindle was related to female age. 
5) Assess whether morphokinetics of the embryo development was related to female 
age. 
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3. Methods  
3.1 Study design 
In this thesis we aimed to explore the impact of female reproductive ageing on assisted 
reproduction treatment, specifically the effects on embryo development and on ovarian cells 
in vitro. In Paper I, we aimed to identify clinical parameters that were associated with ageing 
in a retrospective epidemiological study using a large clinical database. In Papers II and III, 
we tested specific hypotheses on the effect of ageing on ovarian cells and on embryo 
developmental kinetics, and conducted prospective studies using isolated follicle fluid-
derived cells, oocytes, and embryos. 
 
3.2 Methods 
3.2.1 Ovarian stimulation and oocyte retrieval  
Ovarian stimulation was performed according to the mid-luteal phase down-regulation 
protocol. Final follicular maturation was induced with human chorionic gonadotrophin 
(hCG), and ultrasound-guided transvaginal oocyte retrieval was scheduled 34 – 38 hours 
later. The follicle fluid was searched for oocytes under a microscope, and the oocytes were 
placed in IVF media. In Paper II, the follicular fluid was further processed to isolate follicle 
fluid-derived cells. 
 
3.2.2 Gamete assessments and ICSI/IVF procedure 
Intracytoplasmic sperm injection (ICSI) was indicated in case of male factor infertility, 
reduced sperm quality on the day of oocyte retrieval, or history of reduced fertilization with 
in vitro fertilization (IVF). Prior to ICSI, the cumulus cells surrounding the oocytes were gently 
removed and the oocytes were classified according to maturity as germinal vesicle (GV), 
metaphase I (MI), or metaphase II (MII). Prior to IVF, the maturity of the cumulus-oocyte-
complex was evaluated by the appearance of the cumulus mass. Semen samples were 
subjected to either swim-up preparation, gradient centrifugation, or washed with sperm 
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preparation medium. IVF was performed by addition of approximately 100 000 motile 
spermatozoon to each oocyte. ICSI was performed on metaphase II oocytes only. 
 
3.2.3 Meiotic spindle observation 
In Paper III, the oocytes were subjected to polarized light microscopy with the LC-Polscope 
system to visualize the meiotic spindle. Observations were performed 35.5 – 40.5 hours after 
hCG injection on a heated stage to reduce temperature fluctuations. The appearance of a 
spindle and the angle respective from the first polar body were denoted. The image analysis 
was performed by a single trained observer. 
 
3.2.4 Morphological assessments of embryo 
Normal fertilization was determined by appearance of two pronuclei (PN) and two polar 
bodies. In Paper I, the fertilization was assessed 18 – 19 hours post-insemination. In Paper III, 
the oocytes that had been imaged by the Polscope were checked for fertilization 19-20 
hours post injection, whereas in case of the oocytes cultured in the EmbryoScope, the exact 
time point when the two pronuclei were seen was recorded. 
In Paper I, the embryo quality was assessed on day 2 and day 3 after oocyte retrieval (44 – 
45 h and 68 – 69 h post-insemination). The blastomeres were counted and embryos were 
given a blastomere score, where the top score was given to a 4-cell embryo on day 2 and an 
8-cell embryo on day 3. Embryos with fewer or more blastomeres received a lower 
blastomere score. The embryos were also given a morphological score based on embryo 
fragmentation and the blastomere size (even/uneven sized blastomeres). Embryos with no 
fragmentation and equally sized blastomeres achieved the highest morphological score. The 
total embryo score was based on the blastomere score and the morphology score. Top-
quality embryos with both a maximum blastomere score and a maximum morphology score 
were given the maximal total embryo score. Since transferring two embryos may increase 
the possibility of a pregnancy compared to transferring of a single embryo, the sum of scores 
was also calculated. 
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3.2.5 Morphokinetic assessments of embryos 
In Paper III, the microinjected oocytes were subjected to time-lapse recording in the 
EmbryoScope. Images were acquired every 20 minutes in seven focal planes, and both 
morphological assessments (fragmentation, number of cells, size of blastomeres, number of 
nuclei, multinucleation) and key cytokinetic events were evaluated and marked by a single 
trained observer. The cytokinetic events denoted were: second polar body extrusion, 
fertilization, the first mitotic division (t2), second mitosis (t3), third mitosis (t4). The degree 
of fragmentation was recorded as it evolved during embryo development and at the time-
point before transfer. 
 
3.2.6 Studies on isolated ovarian cells and leukocytes in vitro  
Human follicle fluid-derived cells (FFDC) were isolated from follicle aspirates using hemolysis, 
enzymatic and mechanical dispersion, and gradient centrifugation. Peripheral blood-derived 
mononuclear cells (PBMC) were isolated by standard procedures.  
For immunofluorescence microscopy, cells were cultured on glass coverslips, fixed with 
paraformaldehyde, permeabilized, and labelled with primary and secondary antibodies. 
For flow cytometry, cells were either fixed in paraformadehyde or the Cytofix/Cytoperm 
reagent, followed by exposure to primary and secondary antibodies. Analysis was performed 
with a FACScan instrument (BD) using the Cellquest 4.0 software (BD) or FlowJo. Propidium 
iodide (PI) was added immediately before analysis to identify and exclude necrotic cells. 
Binding and uptake of fluorochrome-conjugated bovine serum albumin (BSA) and BSA 
conjugated with advanced glycation end products (AGE-BSA) by cultured FFDC was examined 
with immunofluorescence microscopy and quantitated by flow cytometry. To affirm a 
specific binding of AGE-BSA on the cell surface, the cells were incubated with mannan, D-
mannose or D-galactose as compatitve binding inhibitors.  Activation of apoptosis-associated 
signaling pathways and cell death in FFDC was examined with immunofluorescent 
microscopy and flow cytometry. These experiments included: detection of phospho-NF-κB 
p65 in cells, which would indicate activation of the NF-κB pathway; detection of cleaved 
caspase-3, a key effector of the cell death pathway; binding of annexin V by cells, which 
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indicates phosphatyldilserine switch in the cell membrane during the initial steps of 
apoptosis; detachment of cells during monolayer culture, indicating cell death. 
3.3 Statistical analysis 
In Paper I, association between age and multiple outcome variables was assessed with 
analysis of variance or chi-squared test for trends. The effect of age and treatment 
characteristics on pregnancy odds were analyzed with logistic regression, using univariate 
and multivariate models to assess the effect of a variable alone and after adjusting for 
covariates. 
In Paper II, Pearson correlation, Student`s t test and analysis of variance were calculated as 
appropriate.  
In Paper III, non-linear regression analysis was used to correlate the appearance of the 
meiotic spindle to the degree of fragmentation, and ANOVA for linear trend was used to 
compare the time-points for emergence of pronuclei and mitotic progression of cell cycles to 
fragmentation.  
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4. Summary of results 
Paper I   
Advanced chronological age was found to be associated with fewer oocytes retrieved, fewer 
embryos available for cryopreservation, as well as lower pregnancy, implantation, live birth 
rates, and a higher miscarriage rate. No age-related correlation was found between 
fertilization rates, oocyte or embryo quality assessed as blastomere score, morphology 
score, and the total embryo score of transferred embryos.  
 
Paper II  
GL cells and ovarian monocytes were found to express both AGE and RAGE on the cell 
surface. RAGE-specific fluorescence intensity in GL cells correlated with the patients’ 
chronological age. GL cells, monocytes, and lymphocytes were found to bind AGE-albumin 
(BSA), and the binding of AGE-BSA of GL cells correlated with the patients' chronological age. 
Binding of recombinant human chorionic gonadotrophin to GL cells was not affected by the 
presence of AGE-BSA. In GL cells, AGE-BSA and BSA failed to induce cleavage of caspase-3, 
phosphorylation of NF-κB, and increased binding of annexin V. AGE-fibronectin was found to 
induce detachment of cultured GL cells in vitro. The findings support that ovarian granulosa 
cells and monocytes are exposed to AGEs in vivo, express RAGE, and bind AGEs on the cell 
surface. The ligands of RAGE and their effects in the ovary remain uncertain. Structural long-
lived ECM proteins rather than soluble AGEs may play a role in the decline of ovarian 
function during ageing.  
 
Paper III 
Human embryos with low degree of fragmentation (< 10%) at 42- 45 hours after 
insemination, originated from oocytes with an early appearance of the meiotic spindle 
(35.5.hours after hCG injection), early first mitosis (27.7 hours after insemination), late start 
of the second mitosis (38.5 hours after insemination), and a shorter duration of the third 
mitosis (0.6 hours). Conversely, highly fragmented embryos (> 50 % fragmentation) 
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originated from oocytes with a late appeared meiotic spindle (36.5 hours after hCG 
injection), late start of the first mitosis (28.7 hours after insemination), early start of the 
second mitosis (37.6 hours after insemination), and a longer duration of the third mitotic cell 
cycle (2.2 hours). 
  
Figure 5: Summary of the results presented in Paper III. 
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5. General discussion 
This thesis examined the effect of age on treatment outcome among women undergoing 
assisted reproduction treatment, including morphological assessment of oocytes and 
embryos, visualization of the meiotic spindle, and morphokinetic analysis in a time-lapse 
system. Furthermore, this thesis examined a specific mechanism of ageing, the AGE-RAGE 
system, in cells derived from the ovarian follicle. In Paper I, we found that morphological 
assessments, such as degree of fragmentation, fail to detect age-related impairment in 
oocytes and embryos. This result made us interested in the process and development of 
embryo fragmentation, which was the subject of Paper III. In section 5.2.3 we report 
additional analyses that examined the association between ageing, spindle emergence, and 
embryo fragmentation.  
 
5.1 Methodological considerations 
5.1.1 Paper I 
Paper I is a retrospective study of 4587 women undergoing their first assisted reproduction 
treatment during 1996 – 2007. The paper revealed that morphological assessment done 
routinely at assisted reproduction clinics fails to reflect age-related changes in oocytes and 
embryos. The strength of this paper is that over 43,000 oocytes, 25,000 embryos and 7900 
transferred embryos are assessed. Some limitations are its retrospective nature and that 
patient records were collected over a long period of time. Although a single embryo scoring 
system was used throughout Paper I, many embryologists have contributed to the 
assessments of oocyte and embryo quality in this paper, and it is known that morphological 
assessments are prone to subjectivity 162.  
Standard scoring of cleavage-stage embryos using microscopic evaluation by an 
embryologist has some notable limitations. Firstly, lack of a clearly defined standard method 
to measure and record specific characteristics can lead to loss of important information, and 
different laboratories often assess oocytes and embryos with different scoring systems. 
However, none of these grading systems has been properly validated in terms of reliability.  
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Secondly, as morphology and developmental competence are not firmly correlated, 
morphological assessment is known to have limited predictive value in the identification of 
the most viable embryos 163. A newly published study examined 1213 embryos by 
comprehensive chromosome analysis and revealed that chromosomal abnormalities were 
common among the cleavage stage embryos that had been assigned the best morphological 
scores 164. However, at blastocyst stage aneuploidies were found to be significantly less 
common among top quality blastocysts compared to blastocysts with poor morphology  164. 
Some variation in scoring of morphological parameters can also be expected among 
different embryologists (inter-observer variability) and within the same embryologist (intra-
observer variability) 165. However, many studies affirmed an acceptable intra-observer and 
inter-observer variability during the evaluation of embryo morphology 162, 166, 167.  
Thirdly, due to the workload of the laboratory and the importance of a stable environment 
for the oocytes and the embryos, the morphological assessment may not always be done at 
constant time points and embryos may be scored once or twice a day. Fluctuations in pH and 
temperature may have deleterious effects on oocyte and embryo development 168. Since a 
rapid evaluation is therefore essential, important events may be missed or overlooked, 
especially dynamic processes such as emergence of cellular fragments and multinucleation 
of blastomeres.  
Since the predictive value of oocyte morphology is controversial 169-175, we concentrated on 
assessing the maturity of oocytes. Oocytes fertilized by ICSI were evaluated with the 
cumulus cells removed during the denudation process, whereas oocytes fertilized with the 
IVF were evaluated by assessments of the cumulus-oocyte complex 176,  although this latter 
method may be inaccurate predicting oocyte maturity 177, 178. The embryos were evaluated 
on day 2 and day 3 after ovum pick up for morphological assessment, and were given a 
blastomere score based on the number of blastomeres and a morphology score based on 
the degree of fragmentation and size of the blastomeres. The number of blastomeres has 
been proposed to be the key morphological factor to predict pregnancy and live birth, and 
the ideal cleavage rate on day 2 and day 3 to be four and eight blastomeres, respectively 111, 
114, 179, 180. Therefore, the maximum blastomere score was given to embryos with four 
blastomeres on day 2, and embryos with more or less blastomeres were given lower scores. 
Calculating the blastomere score, there were corrected for abnormal features in the 
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blastomeres (vacuoles, centralized cytoplasm, granularity, vacuoles, symmetry, abnormal 
shape of the blastomeres etc). Each abnormal feature contributed with a minus point to that 
certain embryo's blastomere score.  
Degree of fragmentation and size of blastomeres were defining features of the 
morphological score (Table 1). It is well established that fragmentation is related to lower  
implantation and pregnancy rates and may be indicative of chromosomal abnormalities 118, 
120, 129, 132, 133, 181, 182. The presence of uneven sized blastomeres has been shown to be 
associated with inferior pregnancy and implantation rates and may be related to aneuploidy 
118, 125, 180, 183, 184.  
Table 1: Morphological embryo scoring based on fragmentation and blastomere size. 
Score Description 
4 Equally sized blastomeres and no fragmentation 
3 င10–20% fragmentation, even or uneven blastomeres 
2 >20–50% fragmentation, even or uneven blastomeres 
1 Fragmentation precluded counting blastomeres 
0 Cleavage arrest or morphologically abnormal embryo 
 
5.1.2 Paper II 
In Paper II, we cultured follicle-fluid derived cells isolated from aspirates of ovarian follicles 
from women who underwent assisted reproduction treatment. Since the experiments 
required large numbers of cells, fluids of multiple follicles were pooled, which may imply 
some disadvantages. Firstly, revealing the oocyte and embryo quality of each follicle would 
have been an apprehensive addition to the status of the follicle fluid-derived cells. Secondly, 
number of follicle fluid-derived cells did correlate with the number of follicles/oocytes. 
Women at advanced age, even when the follicles were pooled, had fewer follicles to aspirate 
and therefore fewer cells to be analyzed with the flow cytometer. 
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Immunofluorescence microscopy was used to demonstrate the presence and distribution of 
AGE and RAGE through the cells. For quantitative analysis, flow cytometry was used. We 
aimed to study the effect of AGE on follicle fluid-derived cells, especially the granulosa lutein 
cells (GLC). One obstacle in studying these cells with flow cytometry is that there exists no 
single cell surface antigen, or a combination of multiple markers, that would readily 
distinguish granulosa lutein cells. Instead, we negatively selected contaminating immune 
cells expressing common immune cell markers. Optimally, immune cells could have been 
excluded with fluorescence-activated cell sorting (FACS), a specialized method with which 
cell populations expressing a specific marker can be sorted.  
The isolated granulosa lutein cells were cultured on gelatin-coated dishes in vitro to study 
the intracellular effects of AGE and RAGE activation. The plating density of cells may be an 
important factor due to the differentiation of the granulosa lutein cells. One study has 
reported that a lower plating density could make granulosa cells exhibit estrogen 
production, while at a higher plating density the granulosa cells may appear as progesterone 
producing theca lutein cells 185. It is therefore uncertain whether this may be one obstacle 
with Paper II, due to the fact that we cultured various number of cells per volume of culture 
media depending on the number of follicles aspirated. 
The intracellular response of AGE, binding of AGE to RAGE, and activation of apoptosis were 
studied in Paper II. Intracellular cascades of apoptosis and intracellular responses to RAGE 
activation are numerous. Annexin V was selected as an early marker of apoptosis due to the 
fact that apoptotic cell death is accompanied by loss of phospholipid asymmetry in 
membrane structures and surfacing of phosphotidylserine (PS) on the outer membrane 
leaflet 186. Annexin V positive granulosa lutein cells have been found by others 187, 188.  
Caspases exist as inactive proenzymes that undergo proteolytic processing at conserved 
aspartic residues to produce two subunits, large and small, that dimerize to form the active 
enzyme.  Activation of caspase-3 was examined in Paper II, as it is an effective readout of 
apoptosis in other systems, like neuronal death in Alzheimer's disease 189, 190.  
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Oxidative stress in cultured luteal cells was shown to induce apoptosis through the activation 
of NF-κB 191. Due to the fact that, in Alzheimer disease, NF-κB activation is induced by 
activation of RAGE 192, NF-κB was selected as readout in Paper II.  
 
5.1.3 Paper III 
In Paper III, we used polarized light microscopy to examine the meiotic spindle, which has 
birefringent features. Birefringence is an optical property of highly ordered molecules such 
as microtubules in spindles and oriented glycoproteins in the zona pellucida. The 
birefringent structures are seen as bright structures in a polarized microscope 139. The 
visualization of the meiotic spindle as a marker of oocyte quality is controversial 193. 
Although the polarized light may be harmless to the oocytes, some temperature fluctuations 
may affected our observations, despite the fact that we maintained constant temperature 
by a heated stage 144. The optimal method of visualization of the meiotic spindle would have 
been a time lapse system to study the dynamic nature of the spindle, since meiotic spindles 
disappear and reappear during oocyte maturation 141.  
One obstacle of this study was that there were many embryologists involved in visualization 
of the spindle, but a single trained embryologist analyzed the images.  
In one prior article, the authors found no consistent correlation between morphometric 
evaluations of the spindle through Polscope with confocal analysis by immunostaining of the 
microtubules, and the Polscope was suggested to be an inefficient method for assessing the 
metaphase II spindle and for noninvasive oocyte selection 194. 
Since the first time-lapse study in 1997 by Payne and colleagues 109, morphokinetics has 
added time-lapse evaluations to regular morphology evaluations.  Nonetheless, a recent 
Cochrane report concluded that there is insufficient evidence for improved live birth, 
miscarriage, stillbirth or clinical pregnancy rates in time-lapse systems compared to standard 
incubation 156. Many of the time-lapse studies published are retrospective and the risk of 
bias is strong and difficult to account for. Nevertheless, there are several practical 
advantages of time-lapse systems. Firstly, time-lapse systems provide strictly controlled and 
stable incubation conditions that may be an improvement over regular incubators 151, 153. 
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Secondly, minimal handling of oocytes and embryos inside and outside of the incubator is 
advantageous. The only time-points the embryos are outside the incubator are when loading 
of the oocytes in the EmbryoSlide and during changes of the media at culturing to blastocyst 
stage. Thirdly, time-lapse systems provide more information of the embryo development for 
qualitative evaluation of morphology, especially dynamic processes such as fragmentation 
and multinucleation. Time-lapse monitoring gives the chance to observe the embryo 
continuously and enables the embryologists to detect any changes that occur during embryo 
development. And lastly, quantitative morphokinetic parameters allow selection of viable 
embryos.  As transfer of blastocysts with deviant morphokinetic parameters may result in 
live births 195, a morphokinetic model should be used for ranking rather than selection to 
avoid the risk of discarding usable embryos 196.  
 
For studying the dynamic processes of embryo development, such as cytokinesis, the 
appropriate interval between the images should be defined. Time-lapse systems are 
normally programmed to 20 minutes intervals. To be able to cover rapid processes, it should 
be programmed to 5 min intervals, which several of the various time-lapse systems are 
capable of. Wong et al. predicted the progression to the blastocyst stage with >93% 
sensitivity and specificity by measuring three dynamic, noninvasive imaging parameters by 
day 2 after fertilization, before embryonic genome activation (EGA) 131. Problems during 
cytokinesis, which may cause longer cell cycles, may be both cause and consequence of 
chromosome abnormalities 197. 
 
One obstacle with time-lapse recordings is that start and termination of dynamic events may 
be difficult to define. For example, a specific dynamic event may be regarded to start at its 
initiation, e.g. the first frame of observation, or alternatively, when the feature achieved its 
maximum. Even though the intra-observer and inter-observer consistency of time-lapse 
annotation was shown to be high 198, each laboratory is advised to specify its own 
morphokinetic parameters and to adopt a uniform approach to time-lapse terminology and 
definitions of morphokinetic variables to evolve improved interpretation of time-lapse data 
199.  
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Additional limitations with the time-lapse systems are that 1) embryos are non-adherent and 
may move out of the field of view of the microscope, 2) formation of air bubbles may 
prevent embryo evaluation, 3) difficulties in assessments of number of cells in advanced 
cleavage or blastocyst-stage embryos, and finally 4) assessing the degree of fragmentation in 
high fragmented embryos. Even though the time-lapse system has the possibility to view an 
embryo through different planes, the embryos cannot be rotated. 
The concerns about the prolonged exposure to light in time-lapse systems is likely to be 
unfounded. The different systems use red light, which is believed to be less disturbing for 
the embryo development. One animal study found no significant difference in blastocyst 
development in embryos expelled to red light compared to embryos viewed by a regular 
inverted microscope 200. 
 
5.2 Interpretation of results 
5.2.1 Interpretation of results - ageing and assisted reproduction treatment 
In Paper I, we found that even though younger women received more prolonged stimulation 
with follicle stimulation hormone (FSH) compared to older women, older women received a 
significant higher dose of total FSH. Despite the higher dose of follicle stimulating hormone, 
reduced numbers of oocytes were retrieved, confirming earlier data 201-203. Even though the 
number of oocytes was lower compared to young patients, the quality of oocytes as 
assessed by oocyte maturity was comparable and the fertilization rate were not different 
between the age groups, in agreement with previous reports 203. 
 
In line with others, we also failed to find age-related trends affecting embryo development, 
assessed by the mean morphology score, the mean blastomere scores, and the cumulative 
total score of transferred embryos 204-207. Nonetheless, the association between maternal 
age and embryo quality has been controversial. It has been suggested that maternal age 
does not affect the relationship between euploidy and day-3 morphology 208. Another 
publication reported significantly reduced cleavage in embryos from women of advanced 
age 209. Ziebe and colleagues found no age-related decline in number of blastomeres, but 
described an age-related increase in proportion of fragmentation 201.  
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We found that pregnancy rate, implantation rate and live birth rate declined with increasing 
age, and the miscarriage rate increased, in agreement with previous reports 203, 210. To verify 
that the oocyte and embryo quality scores were correlated with pregnancy, we analyzed the 
effect of age and treatment characteristics on pregnancy odds with logistic regression. Both 
univariate and multivariate analysis gave the similar result and confirmed that age reduces 
the odds for pregnancy, and that the number of oocytes retrieved, oocyte quality score, 
embryo morphology score, embryo blastomere score and cumulative total embryo score of 
transferred embryos contributed to increased odds for pregnancy.  
The results in Paper I may justify the practice of transferring two embryos in women with 
advanced age, even though this might increase the possibility of multiple pregnancies. One 
may still need to develop non-invasive methods to detect age-related impact on gametes 
and embryo development routinely in the laboratories. 
5.2.2 Interpretation of results - ageing and AGEs in the ovary 
We confirmed using immunofluorescence and flow cytometry the expression of AGE and 
RAGE on the surface of follicle-fluid derived cells. Expression of RAGE and binding of AGE-
BSA was found to correlate with the patients' chronological age. AGE-BSA was highly bound 
by GL cells. A potential accumulation of AGEs in the human ovary may account for a number 
of age-related features of ovarian dysfunction, including impaired vascularization and 
consequent hypoxia and reduced intake of nutrients by follicle cells 58. A possible correlation 
of AGE with follicle ageing was first reported by an observational study that found increased 
levels of pentosidine, an AGE compound, in the primordial, primary, and atretic follicles of 
premenopausal women 211. Another study provided evidence for a potential role of AGE 
signaling in the control of the ovarian extracellular matrix during follicular development 212, 
implicating inflammatory mechanisms in ovarian dysfunction during ageing. 
Elevated expression of AGE and RAGE has been found in other reproductive diseases 
connected to inflammation. Studies by Diamanti-Kandarakis and colleagues affirmed the 
presence of AGEs in ovarian tissue of young women and also described increased levels in 
serum and ovary of women with polycystic ovary syndrome (PCOS) 74, 213. The serum levels of 
the soluble form of RAGE, lacking both the cytosolic and the transmembrane domains, has 
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been described to be elevated in patients with polycystic ovarian syndrome (PCOS) 214. Other 
groups examined the role of AGE and RAGE in patients with endometriosis and found 
elevated expression of RAGE in endometriosis compared to healthy endometrial tissue 215. 
Increased serum levels of sRAGE of women with recurrent pregnancy loss (RPL) may indicate 
that AGE-RAGE is involved in RPL 216. It has been reported that maternal sRAGE levels are 
higher in patients with preeclampsia (PE) than in women with normal pregnancies 217, 218, 
further supporting the pathological role of AGE via RAGE, probably involving inflammation.  
There have been several reports connecting AGE-RAGE to outcome of assisted reproduction 
treatments. Levels of sRAGE in the follicle fluid of patients undergoing assisted reproduction 
treatments have been found to correlate negatively with the total gonadotropin dosage 
needed per cycle, independently of age, BMI, or day 3 serum FSH level. Follicular fluid sRAGE 
levels were also suggested to predict the number of oocytes retrieved 219. This latter study 
also reported that concentration of sRAGE in the follicular fluid was several-fold higher 
compared to serum and most other biological fluids, suggesting a preferential accumulation 
of sRAGE in the follicular environment 220. In addition, it was reported that serum sRAGE 
correlates negatively with the number of follicles and oocytes, together with high follicular 
sRAGE levels, in particular in women who conceive. Indeed, plasma concentration of sRAGE 
was found to be significantly higher among young women, and the level of sRAGE found in 
the follicle fluid showed a tendency of positive correlation with the number of oocytes 
retrieved 221. A positive correlation between levels of sRAGE in follicular fluid and follicular 
fluid levels of anti-Müllerian hormone (AMH) was also described 219. Jinno et al. 222 found 
that accumulation of the so-called toxic AGE (TAGE) in follicular fluid and in serum correlated 
negatively with follicular growth, fertilization, and embryonic development. TAGE correlated 
positively with altered glucose metabolism, age, and factors related to obesity, dyslipidemia, 
hyperglycemia, and insulin resistance.  
In Paper II, we found that exposure of cells to AGE-BSA up to a concentration of 200 μg/ml 
failed to activate markers of apoptosis, such as annexin V, caspase -3 and NF-кB. Reber and 
colleagues reported that exposure of neural cells and glial cells to 500 nM AGE-BSA was not 
followed by apoptotic or necrotic cell death 190. In ovarian granulosa-lutein cells, activation 
of NF-кB and caspase-3 was associated with a high rate of apoptosis, in particular during the 
late luteal phase 191. In neurons, it has been shown that methylglyoxal, a precursor of 
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advanced end glycations, triggers apoptosis by inducing activation of caspase-3, suggesting a 
role of AGEs in neurodegeneration in Alzheimer`s disease 189. We found that AGE-fibronectin 
induced follicular-fluid derived cell death, which may imply that, rather than soluble AGE, 
modification of structural long-lived extracellular matrix proteins by AGE may be a culprit in 
the ovarian dysfunction of ageing. 
Notably, by using staurosporine, which is a known inducer of apoptosis through activation of 
caspase-3 223, we failed to observe activation of the apoptotic marker annexin V and 
cleavage of caspase-3 in GL cells. Wang et al. studied apoptosis in granulosa cells from rat by 
Western blot (caspase-3) and nuclear morphology (Hoechst staining) and found no 
significant effect of treatment by staurosporine 224. The lack of effect by staurosporine on 
apoptosis was suggested to be due to differentiation of granulosa cells. Others have found 
evidence of apoptosis, including cell detachment, membrane shrinkage and formation of 
apoptotic bodies in luteinized granulosa cells treated with staurosporine 225. However, 
Western blot analysis has also revealed activation of several parts of the apoptosis pathway 
(cleavage of caspase-9, caspase-3, poly-(ADP-ribose)-polymerase (PARP)),  in staurosporine-
treated cells, suggesting that it may serve as a useful model to delineate the mechanism of 
apoptosis in the ovary, including the regression of the corpus luteum 225. 
 
In Paper II, we also exposed granulosa-lutein cells to the NF-кB activator phorbol 12-
myristate 13-acetate (PMA). PMA is a diester of phorbol and a potent tumor promoter, often 
employed in biomedical research to activate the signal transduction enzyme protein kinase C 
PKC 226. In our study, PMA failed to activate apoptosis in cultured GL cells. One interesting 
experiment demonstrated that PMA, at several concentrations, stimulated cumulus 
expansion 227. Surprisingly, these authors reported that PMA, at low levels, enhanced oocyte 
competence as reflected by assessments of blastocysts yield (more than 45% blastocysts) 227. 
Others detected that PMA at a low concentration mainly act on the cumulus cells, whereas 
PMA at high concentrations also act on the oocytes 228. 
 
The results of Paper II suggest that AGE and RAGE have a role in ovarian ageing, even though 
the physical ligands of RAGE and the effect of the up-regulation of RAGEs is still unknown, 
and the significance of AGE and RAGE in follicular health needs further investigation. Future 
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research focusing on understanding the clinical effect of AGEs on germ cells, aged oocytes, 
mitochondrial dysfunction and follicular microenvironment during different stages of 
development is needed. 
 
5.2.3 Interpretation of results - embryo fragmentation  
In Paper III, we aimed to study the determinants of fragmentation during embryo 
development by assessing the timing of meiotic spindle emergence and the timing of 
mitotic cell divisions. Although the mechanisms that link delayed meiosis to embryo 
fragmentation remain speculative, our results indicate that fragmentation may be 
related to the progress of the meiotic cell cycle and the early mitotic cell cycles. A newly 
published study reported that human oocytes assembled a meiotic spindle 
independently of either centrosomes or other microtubule organizing centers (MTOCs), 
which render efficient spindle assembly and chromosome segregation 229. The authors 
reported a surprisingly slow (~ 16 hours) and gradual build-up of a bipolar spindle with 
aligned chromosomes in human oocytes in contrast to mitosis or oocytes from mice 229. 
The spindle assembly period was characterized by spindle instability and abnormal 
kinetochore-microtubule attachments, which may cause chromosome segregation 
errors and may explain the high rates of aneuploidy in human oocytes 229. The timing of 
the process of fragmentation in relation to the cell cycle has also been studied by Alikani 
and collaborators. Their results show that fragmentation does not occur in mitotically 
inactive cells, but emerges in actively dividing cells during cytokinesis, probably in 
response to altered cytoskeletal organization 130. Others has concluded that 
fragmentation of oocytes is a result of an apoptotic process from DNA damage, such as 
failure of chromosomes and/or centromeres to form a functional meiotic spindle 230.  
It is well known that highly fragmented embryos are often chromosomally abnormal 133, 
raising the possibility that fragmentation was associated with ageing-related aneuploidies. 
Therefore we also examined, using data in Paper III, whether the spindle emergence and 
time-lapse time-points were correlating with age. 
Battaglia et al. has previously reported that oocytes derived form aged women display 
abnormal spindles 231. However, we found no correlation between the women's age and the 
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appearance of the meiotic spindle by polarized light microscopy (Figure 6). Time-lapse 
recordings also failed to uncover correlation between advanced age and morphokinetics 
(Figure 7 and Figure 8).  
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These results may indicate that the abnormalities in human embryos connected to 
fragmentation may involve different processes than the mechanisms causing abnormalities 
in oocytes and embryos from aged women. 
Reduced spindle retardance has been associated with poor embryo quality of aged patients, 
although, in general, no association was apparent between retardance and embryo 
development 232. Reduced percentage of visible spindle and reduced mean spindle 
retardance were shown to be related to age 233. Oocytes derived from aged mice have been 
found to have a more prolonged meiosis I and increasingly failed to progress to MII 
compared to oocytes from young mice 234. There have also been reports of an accelerated 
meiosis I, increase of abnormal meiosis II, spontaneous oocyte activation, and cellular 
fragmentation in oocytes derived from aged mice 16, 235.  
 
Oocytes from women of advanced age may have cytoplasmic and nuclear maturation 
asynchrony due to derangements of hormonal homeostasis, size of the follicle pool, or 
interaction between oocytes and somatic compartments, which may cause errors in 
chromosome segregation and effect meiosis and effect fertility 16. Loss of co-ordination 
between nuclear maturation and cytokinesis may suggest age-related relaxed cell cycle 
control 236. MAD2 is a checkpoint protein known to play a crucial role in meiosis I. 
Overexpression of MAD2 in meiosis I may lead to cell cycle arrest in metaphase I in mouse 
oocytes, and downregulation of MAD2 is correlated with a shortened duration of meiosis I 
and increased oocyte aneuploidy 42, 237. The impairment of checkpoint function and loss of 
chromatid cohesion caused by reduced transcription of MAD2 and the cohesin SMCβ1 found 
in aged oocytes from human and mice, are suggested to contribute to age-related 
aneuploidy 236, 238. Additionally, analysis of gene expression in human oocytes found that 
expression of genes related to cell cycle regulation, cytoskeletal structure, energy pathways, 
transcription control, and stress responses, are influenced by maternal age 239. 
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6. Conclusions and future perspectives  
Emergence of aneuploidy in oocytes from ageing women appears to be the result of several 
events rather than an insufficiency in a single mechanism. Reduced number and distribution 
of chiasmata formed during early prophase I together with weakened centromeric cohesion 
are probable causes of ovarian ageing. This, in combination with the absence or insufficiency 
of mechanisms to detect and correct erroneously attached chromosomes in oocytes, results 
in an increased rate of aneuploidy. Our results suggest that the abnormalities involved in 
fragmentation of human embryos are distinct from abnormalities seen in oocytes and 
embryos from aged women. 
Our findings on the presence of advanced glycation end products on follicular-derived cells 
suggest that AGEs may be involved in decline of ovarian function. We propose that AGEs in 
form of structural long-lived extracellular matrix (ECM) proteins, rather than soluble AGEs 
may play a role in ovarian ageing, which suggests promising candidates for future research. 
In particular, modification of long-lived structural proteins in the ECM and on the cell 
surface, their putative role of activation of inflammation, and the protective role of sRAGE 
should be examined.  
At present, there is no consensus on the optimal way to determine the competence of 
human embryos derived from in vitro fertilization or to select the most competent embryos 
for transfer despite recent advances in both invasive and non-invasive techniques. Our 
results imply that non-invasive technologies used in assisted reproduction laboratories, 
including morphology assessments, morphokinetics, and meiotic spindle evaluations with 
polarized light, fail to detect age-related impairment of oocytes and embryos.  
 
As women continue to postpone the birth of their first child, the society should dedicate 
more attention to the effects of ageing on fertility, which may mandate ovarian reserve 
assessment, patient education, and early intervention. 
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